{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:03:58Z","timestamp":1789193038696,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"\n Introduction:<\/jats:title>\n Therapeutic plasma exchange (TPE) is an extracorporeal process of separation of plasma from the cellular components of blood and its replacement with analogous fluids. This process is effective in treatment of disease conditions from dysregulation of the humoral immune system by removal of various humoral pathogenic substances like antibodies, immune complexes, monoclonal proteins, toxins or cytokine(s) and\/or the replenishment of a specific plasma factor.<\/jats:p>\n <\/jats:sec>\n \n Aim and Objective:<\/jats:title>\n To evaluate major indications of therapeutic plasma exchange in neurological disorders. To identify major complications associated and factors associated with premature cessation of the therapeutic plasma exchange cycle. Materials and Methods: This is a hospital based retrospective study conducted by analyzing medical records of patients, who had undergone therapeutic plasma exchange (TPE) for various neurological disorders at IMS & SUM hospital. Medical records total 118 patients who underwent TPE from January 2016 to December 2021 were analyzed. The demographic data, blood group pattern and indications for TPE were enumerated from the records. Various complications of TPE and reasons for incomplete TPE cycle were documented and analyzed.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n A total of 508 TPE procedures were performed on 118 patients. In this study 61 patients were male and 57 patients were female. O-blood group was commonest blood group among the patients. GBS is the commonest indication of TPE. 57.6 % of patients could complete all sessions TPE cycle. Blockage of vascular access is the commonest cause of incomplete TPE session. Cramps (33%) and mild transient hypotension (27.1%0 were the commonest complications observed.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n TPE is a safe and effective treatment option for various immune-mediated neurological disorders and should be considered in managing these disorders.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/aam.aam_65_24","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T01:00:07Z","timestamp":1726448407000},"page":"649-655","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic Plasma Exchange in Neurological Conditions: An Observation from the Eastern Part of India"],"prefix":"10.4103","volume":"23","author":[{"given":"Ajit Prasad","family":"Mishra","sequence":"first","affiliation":[{"name":"Department of Neurology, IMS and SUM Hospital, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikant Kumar","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Neurology, IMS and SUM Hospital, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girijanandini","family":"Kanungo","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, IMS and SUM Hospital, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulup Kumar","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Neurology, IMS and SUM Hospital, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhankar","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Neurology, IMS and SUM Hospital, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraprava","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Pathology, S. C. B. Medical College, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jca.21257","article-title":"Therapeutic plasma exchange: A technical and operational review","volume":"28","author":"Kaplan","year":"2013","journal-title":"J Clin Apher"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jca.2920080402","article-title":"An overview of current management","volume":"8","author":"Srauss","year":"1993","journal-title":"J Clin Apher"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s001340050595","article-title":"Role of replacement fluids in the immediate complications of plasma exchange. French registry cooperative group","volume":"24","author":"Korach","year":"1998","journal-title":"Intensive Care Med"},{"key":"R4-20260427","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0887-7963(88)70031-0","article-title":"The use of therapeutic plasmapheresis for neurological disorders","volume":"2","year":"1988","journal-title":"Transfus Med Rev"},{"issue":"Suppl 6","key":"R5-20260427","first-page":"S22","article-title":"Circulating adhesion molecules and inflammatory mediators in demyelination: A review","volume":"45","author":"Hartung","year":"1995","journal-title":"Neurology"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/00003246-199910000-00003","article-title":"Continuous plasma filtration in sepsis syndrome. Plasmafiltration in sepsis study group","volume":"27","author":"Reeves","year":"1997","journal-title":"Crit Care Med"},{"key":"R7-20260427","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1526-0968.2001.00386.x","article-title":"Plasmapheresis affects T helper type 1\/T helper type 2 balance of circulating peripheral lymphocytes","volume":"5","author":"Goto","year":"2001","journal-title":"Ther Apher"},{"key":"R8-20260427","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajh.20342","article-title":"Effect of plasma exchange on cytokines measured by multianalyte bead array in thrombotic thrombocytopenic purpura","volume":"79","author":"Shariatmadar","year":"2005","journal-title":"Am J Haematol"},{"key":"R9-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.2920090102","article-title":"Complications of therapeutic plasma exchange: Recent assessment","volume":"9","author":"Couriel","year":"1994","journal-title":"J Clin Apher"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0272-6386(12)80135-1","article-title":"Therapeutic plasma exchange: Complications and management","volume":"23","author":"Mokryzicki","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R11-20260427","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00003246-199305000-00006","article-title":"Plasma exchange morbidity in GBS: Results from the French prospective, randomised, multicentre study. French cooperative group","volume":"21","author":"Bouget","year":"1993","journal-title":"Crit Care Med"},{"key":"R12-20260427","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0972-2327.144301","article-title":"Plasmapheresis in neurological disorders: Experience from a tertiary care hospital in South India","volume":"18","author":"Gafoor","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"key":"R13-20260427","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin and combined treatments in Guillain Barre syndrome","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"R14-20260427","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00019052-200210000-00008","article-title":"Acute immunoinflammatory neuropathy: Update on Guillain-Barre syndrome","volume":"15","author":"Hartung","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"R15-20260427","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomised trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain Barre study group","volume":"326","author":"van der Meche","year":"1992","journal-title":"N Engl J Med"},{"key":"R16-20260427","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: Plasmapheresis in neurologic disorders: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jca.21224","article-title":"Therapeutic apheresis in pediatrics: Technique adjustments, indications and nonindications, a plasma exchange focus","volume":"27","author":"Wong","year":"2012","journal-title":"J Clin Apher"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1744-9987.2009.00793.x","article-title":"Plasma exchange in elderly patients","volume":"14","author":"Basic-Jukic","year":"2010","journal-title":"Ther Apher Dial"},{"key":"R19-20260427","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jca.20143","article-title":"Complications of therapeutic plasma exchange: A prospective study of 1,727 procedures","volume":"22","author":"Shemin","year":"2007","journal-title":"J Clin Apher"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.transci.2011.09.002","article-title":"Scope and application of therapeutic apheresis: Experience from a tertiary care hospital in North India","volume":"45","author":"Sharma","year":"2011","journal-title":"Transfus Apher Sci"},{"key":"R21-20260427","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jca.20302","article-title":"Conventional apheresis therapies: A review","volume":"26","author":"Ward","year":"2011","journal-title":"J Clin Apher"},{"key":"R22-20260427","doi-asserted-by":"crossref","first-page":"1234.","DOI":"10.12688\/f1000research.11841.1","article-title":"Plasmapheresis in neurological disorders: Six years experience from University clinical center Tuzla","volume":"6","author":"Sinanovi\u0107","year":"2017","journal-title":"F1000Res"},{"key":"R23-20260427","doi-asserted-by":"crossref","first-page":"e18308.","DOI":"10.1097\/MD.0000000000018308","article-title":"Complications of therapeutic plasma exchange: A retrospective study of 1201 procedures in 435 children","volume":"98","author":"Lu","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_65_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:40:24Z","timestamp":1787773224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_65_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_65_24","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"2024-04-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}